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TNF Regulates the In Vivo Occupancy of
Both Distal and Proximal Regulatory Regions
of the MCP-1/JE Gene
Dongsheng Ping, Peter L. Jones, TNF-induced genes involves the activation and translo-
cation to the nucleus of the transcription factor NF-and Jeremy M. Boss
kB. Once in the nucleus, NF-kB presumably binds itsDepartment of Microbiology and Immunology
respective cis-acting regulatory element and activatesEmory University School of Medicine
expression (Schutze et al., 1992; Siebenlist et al., 1994;Atlanta, Georgia 30322
Mackman, 1995; Schindler and Baichwal, 1994; Ito et
al., 1994; Collins et al., 1995; Krikos et al., 1992; Osborn
et al., 1989; Mukaida et al., 1990). However, experiments
Summary involving the TNF induction of several genes indicate
that NF-kB does not function alone but rather forms
In vivo genomic footprinting (IVGF) was used to exam- cooperative interactions with other factors, which are
ine regulatory site occupancy during the activation of required for expression (Mackman, 1995; Collins et al.,
the murine inflammatory response gene MCP-1/JE by 1995). Some models propose that NF-kB-mediated gene
TNF. In response to TNF, both promoter distal and expression involves the formation of a multiprotein com-
proximal regulatory regions became occupied in vivo. plex termed an enhanceosome (Thanos and Maniatis,
EMSA analysis showed that while some of the factors 1995b; Collins et al., 1995). Because these models are
involved in expression, including NF-kB, were translo- based on in vitro experimentation, the actual assembly
cated to the nucleus following TNF treatment, others of factors and their dependence on NF-kB has yet to
were already present and able to bind DNA in vitro. be determined in vivo.
Protein kinase inhibitor studies showed that protein Human monocyte chemoattractant protein-1 (MCP-1)
phosphorylation was required for TNF activation but and its murine homolog, encoded by the JE gene, are
not factor assembly. These studies provide evidence small basic proteins that specifically attract and activate
for a multistep model ofTNF-mediated generegulation monocytes tosites of inflammation (Rollins, 1991). MCP-
involving chromatin accessibility, transcription factor 1/JE belongs to the CC chemokine family (Baggiolini
complex assembly, and protein phosphorylation. and Dahinden, 1994) and functions in normal wound
healing, the pathogenesis of atherosclerosis (Schwartz
et al., 1991), the inflammatory process (Baggiolini and
Introduction Dahinden, 1994), and modulation of tumor immunity
(Mantovani et al., 1993). MCP-1/JE is transcriptionally
Tumor necrosis factor a (TNFa) is a pleiotropic cytokine induced immediately after exposure to TNF (Gordon et
that plays an important role in inflammation (Beutler al., 1992; Hanazawa et al., 1993; Satriano et al., 1993).
and Grau, 1993), immunomodulation (Schattner, 1994), Transient transfection of the wild-type and mutant hu-
cachexia (Cerami, 1992), septic shock (Cerami, 1992; man MCP-1/JE reporter constructions have indicated
Tracey and Cerami, 1994), diabetes (Hotamisligil and that two promoter distal kB sites are important for TNF
Spiegelman, 1994), as well as other biological processes induction (Ueda et al., 1994). Other studies have sug-
(Sidhu and Bollon, 1993; Tracey and Cerami, 1993; gested that TNF-mediated induction of the murine MCP-
Birkedal-Hansen, 1993). The induction of such diverse 1/JE gene involves a promoter proximal AP-1 site (Hana-
functions by TNF is mediated through two distinct sur- zawa et al., 1993, 1994). A recent report identified an
face receptors (Sidhu and Bollon, 1993), TNF-R1 (55 additional distal NF-kB binding site in the murine MCP-
kDa) and TNF-R2 (75 kDa). Both TNF-R1 and TNF-R2 1/JE gene and showed that this site could bind NF-
are type II transmembrane proteins having homologous kB and activate expression of a heterologous promoter
extracellular TNF-binding domains but different cyto- (Freter et al., 1995). Taken together, these studies sug-
plasmic domains. The binding of TNF to these receptors gest that the TNF regulation of MCP-1/JE may also re-
results in receptor oligomerization and activation of sev- quire the formation of multiprotein complexes con-
eral signaling pathways that include the sphingomyelin taining NF-kB.
(Kolesnick and Golde, 1994) and phospholipid pathways Because models of TNF-regulated gene expression
(Sidhu and Bollon, 1993). Separately or cooperatively, have been based on in vitro DNA binding protocols, the
these signaling pathways induce a wide spectrum of in vivo state of the regulatory regions of TNF-induced
cell type±specific genes responsible for thepleiotropism genes is not known. To examine the assembly of factors
of TNF (Sidhu and Bollon, 1993; Gordon et al., 1992). in response to TNF induction, in vivo genomic foot-
Such genes include transcription factors (Kronke et al., printing (IVGF) of the murine MCP-1/JE upstream re-
1992), cytokines (Kronke et al., 1992), cell surface recep- gions that correlated with TNF induction was performed.
tors, and oxidative damage repair enzymes (Wong and IVGF provides a snapshot of the occupancy of the regu-
Goeddel, 1988; Visner et al., 1990). Additionally, TNF latory sites of a gene before and during exposure to
modulates cellular immune responses by regulating TNF, and thus can potentially identify sites that are truly
genes involved in antigenprocessing, such as HLA class involved in expression. To correlate MCP-1/JE expres-
I and class II genes (Kronke et al., 1992). sion levels and transcription factor DNA binding activi-
The molecular mechanisms by which TNF activates ties with the IVGF analysis, Northern blot analysis and
expression of genes in a cell type±specific manner are electrophoretic mobility shift assays (EMSAs) were per-
formed. We found that in untreated cells, guanines inunknown. One mechanism that is shared among many
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human MCP-1/JE gene (Ueda et al., 1994), the region
between 22390 and 22342 (the distal regulatory region)
of the murine gene contains two kB sites, termed kB-1
and kB-2 (Figure 1). An additional kB site, (kB-x), which
was identified by Freter et al. (1995), is located in the
region between 22527 and 22502. The region between
kB-x and kB-1 contains two cis elements, termed ele-
ments II and III (Figure 1, not shown), that function in
the platelet-derived growth factor induction of MCP-1/Figure 1. Induction of the MCP-1/JE Gene by TNF Requires the
JE (Freter et al., 1995). Site A (Figure 1) contains elementDistal Regulatory Region
III. The proximal regulatory region contains a third kBSchematic maps of the MCP-1/JE upstream DNA sequence with
site, (kB-3), an AP-1 binding site, a GC box, and a TATAthe indicated cis-acting control elements and the MCP-1/JE±CAT
reporter constructions are shown. Transient transfections of each box (Figure 1).
plasmid were carried out as described in the materials and methods. To identify the TNF-response elements of the murine
CAT protein concentration is plotted as the fold induction for each MCP-1/JE gene, a 2724 bp fragment (22642 to 182
construction of the TNF-treated sample divided by the untreated
with respect to the MCP-1/JE start of transcription) wascontrol sample. The standard deviation from the mean is presented.
amplified by polymerase chain reaction (PCR) of BALB/The results of Student's t test comparisons between samples were
3T3 mouse DNA and fused to the coding region of theas follows: pJECAT2.6 and pJECAT2.5, p 5 0.0188; pJECAT2.6 and
pJECAT2.4, p 5 0.0068; pJECAT2.5 and pJECAT2.4, P < 0.0001; chloramphenicol acetyltransferase (CAT) gene. The re-
and pJECAT2.3 and pJECAT0.3, p 5 0.8441. sulting reporter construct was termed pJECAT2.6. A
38-fold increase in the concentration of CAT protein was
observed following the transient transfection of pJE-
the majority of the regulatory regions were sensitive to CAT2.6 into NIH 3T3 cells that were treated with TNF
dimethyl sulfate (DMS) methylation, indicating that these versus control transfectants (Figure 1). Therefore, this
sites were unoccupied by DNA-binding factors. These 2724 bp fragment contains TNF-response elements. To
methylation-sensitive regions included sites that bind delineate further the region required for TNF inducibility,
factors that were readily detected in the nuclear extracts four 59 deletion constructs were generated having
by EMSA. Upon TNF treatment, sites encoding the two 2505 bp (pJECAT2.5), 2390 bp (pJECAT2.4), 2342 bp
distal kB sites, a proximal GC box, and two new sites (pJECAT2.3), and 322 bp (pJECAT0.3) of upstream se-
became resistant to DMS methylation, and therefore quence. Transient transfection experiments were again
represent specific regions that were occupied by DNA- carried out (Figure 1) and showed that the region be-
binding proteins. Treatment of cells with cycloheximide tween 22505 and 22342was required for TNF-mediated
(CHX) or pyrrolidinedithiocarbamate (PDTC, an inhibitor induction (Figure 1). The region between 2322 and 21
of NF-kB activation), revealed differential binding and (the proximal regulatory region) was only sufficient to
separated the functions of the distal and proximal regu- maintain a low level of transcriptional activity in the
latory regions,suggesting that full induction may require presence of TNF. A negative element may reside be-
interactions between these two regions. Inhibition of tween 22642 and 22505, as TNF-induced expression
cellular protein kinase activity with H7 blocked TNF in- increased following its deletion; however, the overall
duction of MCP-1/JE but did not prevent the TNF-in- effect of this site was less than 2-fold. Together, these
duced binding of transcription factors to any of the sites data suggest a complex regulatorymechanism involving
examined, suggesting that at least one of the regulatory both distal and proximal regulatory regions. However,
factors requires phosphorylation for transcriptional acti- the above transient transfection experiments did not
vation but not binding. Together, these studies begin to determine whether all of these sites function together
outline the components of a complex regulatory system or are actually used during induction by TNF.
for the inflammatory gene MCP-1/JE and suggest a
model of TNF-mediated gene induction that involves the
global induction of transcription factor occupancy that Both the Proximal and Distal Regulatory Regions
Become Occupied by Transcription Factorsmay apply to other TNF-regulated genes. Thus, the abil-
ity of TNF to induce expression in a cell type±specific Following Treatment by TNF
To determine the in vivo role of each of these sites infashion may depend on the availability of regulatory
sites, the profile of nuclear DNA-binding factors, and the expression of MCP-1/JE, IVGF for both the proximal
and distal regulatory regions of the MCP-1/JE gene wasthe ability to kinase one or more transcription factors.
carried out in the presence and absence of TNF. To
correlate the level of MCP-1/JE mRNA expression with
the IVGF, RNA blot analysis was performed. In controlResults
untreated BALB/3T3 cells, the basal level of MCP-1/JE
mRNA is barely detectable by RNA analysis (Figure 2A).Identification of TNF-Response Elements
in the Murine MCP-1/JE Gene In these control cells, IVGF showed that with the excep-
tion of site A (-2437 and 22417), which showed bothSequence analysis and studies from other groups have
revealed several DNA-binding consensus elements that DMS-resistant and DMS-hypersensitive sites, no differ-
ences between the in vitro and the in vivo methylationcould function in the TNF control of the murine MCP-1/
JE gene (Figure 1) (Rollins et al., 1988; Timmers et al., protection pattern could be discerned (Figures 2B and
2C; lanes V and 0). Thus, while site A appears to be1990; Ueda et al., 1994; Freter et al., 1995). As with the
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occupied prior to TNF treatment, the distal and proximal it is likely that the kB-3 site binds a factor other than
NF-kB. The TNF-mediated occupancy of both the distalregulatory regions are unoccupied when MCP-1/JE ex-
pression is low. Interestingly, site A was found pre- and proximal regulatory regions suggests that prior to
induction either the DNA-binding factors are not presentviously tobe important in platelet-derivedgrowth factor±
regulated expression of MCP-1/JE (Freter et al., 1995). in the nucleus, the DNA is inaccessible to the DNA-
binding proteins, or that theassembly of factors requiresAs previously described, the addition of TNF to fibro-
blasts induces the expression of MCP-1/JE dramatically the induction or modification of one or more factors. It
is also possible that all of these mechanisms are in-and immediately (Gordon et al., 1992). Maximal levels
of MCP-1/JE mRNA were achieved at 4 hr following TNF volved in controlling factor occupancy.
addition and remained at this level through 24 hr of
TNF treatment (Figure 2A). Corresponding directly to TNF-Mediated Binding of Transcription Factors
the TNF induction of MCP-1/JE mRNA, the binding of to the Distal Regulatory Region Is Partially Inhibited
factors in vivo to both the distal and proximal regulatory by CHX, Whereas the Binding of Transcription
regions of MCP-1/JE was observed (Figures 2B and 2C). Factors to the Proximal Regulatory Region
After 30 min of TNF treatment, full occupancy of both Is Induced by CHX
kB-1 and kB-2 sites was observed. This occupancy is To determine whether the binding of factors to the TNF-
defined by both DMS-resistant and DMS-hypersensitive response elements requires de novo protein synthesis,
sites. The DMS protection pattern is consistent through CHX was added to the cells 2 hr prior to TNF treatment.
4 hr of TNF treatment; however, at 24 hr, there is a Incubation of cells with CHX alone increased the basal
decrease in protection at some of the bases within the level of the MCP-1/JE mRNA by 36-fold. Subsequent
region (G22378, G22377, G22376, G22352, G22351 of the coding TNF treatment increased the overall induction of MCP-
strand, and G22370, G22369, G22344, G22343 of the noncoding 1/JE an additional 2-fold over control cells (Figure 3A).
strand) (Figure 2B). The full protection of kB-1 and -2 As determined by IVGF, treatment of cells with CHX
sites induced by TNF suggests that TNF treatment of alone did not result in the induction of factor binding to
cells initiates the binding of transcription factors in all the distal regulatory region (Figure 3B, lanes V, 1, and
or most of the cells within the culture. The decrease in 3). Treatment of cells with CHX prior to addition of TNF
protection at some base pairs within the distal kB sites abolished TNF-induced factor binding to kB-1 and par-
following extensive treatment with TNF may suggest tially inhibited TNF-induced factor binding to kB-2. The
dissociation of factors from the sites in some of the cells intensity of DMS-hypersensitive sites in the distal regu-
within the culture. This binding pattern correlates with latory region was also decreased (Figure 3B, lanes 2
the TNF-mediated activation profile of NF-kB for other and 4). Thus, the decrease in binding activityof the distal
genes in which the highest activity of in vitro NF-kB
kB sites in cells treated with CHX and TNF correlates
binding was observed after 30 min of TNF treatment, with the lowered fold-induction of mRNA, suggesting
followed by a gradual reduction in binding activity during that full activity of the distal regulatory region may re-
prolonged TNF treatment (Thompson et al., 1995). Thus, quire the synthesis of a labile factor, whose activity is
these data support the hypothesis that these sites bind lost after 2 hr of CHX treatment. Additionally, the re-
NF-kB in vivo. sponses to CHX treatment were different between kB-1
TNF treatment also results in the induction of DMS- and kB-2, implying that these sites may bind either dif-
hypersensitive sites in the distal regulatory region. The ferent NF-kB family members or complexes. In contrast,
DMS-hypersensitive sites are located in the center of CHX treatment did result in an IVGF pattern in the proxi-
kB-2 (G22350 of the coding strand), and between kB-1 mal regulatory region that was similar to that observed
and kB-2 (A22357 and G22356 of the coding strand, and with TNF treatment (Figure 3C), suggesting that the
T22365, G22364, A22363, G22361, and G22360 of the noncoding proximal sites are likely to be responsible for the ob-
strand; Figure 2B). Hypersensitivity of these positions served increase in basal expression.
to DMS implies that TNF-induced occupancy results in
conformational changes in the DNA that may be due to
Inhibition of Cellular Protein Kinase Activity ResultsDNA bending, the binding of additional factors, or both
in Loss of Transcription of MCP-1/JE, but Not(Spana and Corces, 1990).
in the Loss of Regulatory Region OccupancyThe proximal regulatory region was also occupied at
H7 is a general serine/threonine protein kinase inhibitorseveral sites after 30 min of TNF treatment. Protection
that blocks signal transduction through protein kinasewas observed at the GC box, the 59 end of the kB-3
C, protein kinase A, and other similar kinases. Pre-site, G250 bp of the AP-1 site, and a novel site located
viously, H7 has been shown to inhibit the induction ofat 274 to 272 bp (termed site B). These sites remained
MCP-1/JE by TNF (Hanazawa et al., 1993). However, inprotected after 24 hr of TNF treatment (Figure 2C). Nota-
other studies TNF-induced activation and nuclear trans-bly, the protection pattern at the kB-3 site was distinct
location of NF-kB proteins was not influenced by H7from that of the distal kB-1 and kB-2 sites in that only
addition (Meichle et al., 1990). To determine whethera single base pair, G2154, was protected at the kB-3 site.
transcription factor assembly on DNA was affected byIn contrast, the guanine residues at the 59 and 39 ends
the absence of protein kinase activity, IVGF was carriedof both kB-1 and kB-2 sites were protected.Additionally,
out in thepresence of H7. As shown by RNA blot analysisG2154 was fully protected after 24 hr of TNF treatment,
in Figure 4A, H7 inhibited TNF-mediated induction ofwhereas full protection at kB-1 and kB-2 sites was lost.
MCP-1/JE mRNA when added 1 hr prior to TNF treat-Because the other protected base pair in the region of
kB-3 is G2156, which is located outside of the kB-3 site, ment. This effect does not appear to be general, as the
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Figure 2. Induction of MCP-1/JE by TNF Results in the Immediate Binding of Transcription Factors to Both the Distal and Proximal Regulatory
Regions
Northern blot analyses (A) of RNA prepared from BALB/3T3 fibroblasts after TNF treatment for the indicated time are shown with two probes,
MCP-1/JE and GAPDH (control). IVGF carried out for the MCP-1/JE gene on cells treated with TNF for the indicated times are shown for the
distal (B) and the proximal (C) regulatory regions. Lanes marked with V indicate in vitro methylated DNA and lanes marked by 0 represent the
samples from control or untreated cells. Arrows indicate the constitutive changes from in vitro DNA that result in the DMS-resistant bases
(open) and DMS-hypersensitive bases (closed). The circles indicate the TNF-induced binding of transcription factors that results in the DMS-
resistant bases (open) and DMS-hypersensitive bases (closed). Brackets on the left side of the sequences delineate the binding sites as
described in the text and Figure 1. A sequence summary labeled as above is presented.
(Figure 2 continued top of next page)
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RNA levels for the glyceraldehyde phosphate dehydro- with PDTC and TNF resulted in only an additional 3-fold
induction over PDTC treatment alone (Figure 4A). Whilegenase gene (GAPDH) control was not affected by H7
treatment. Interestingly, IVGF analysis showed that H7 IVGF of cells treated with PDTC alone showed noprotec-
tion at kB-1 and kB-2 sites, the DMS hypersensitivity atdid not prevent the TNF-induced binding of transcrip-
tional factors to any of the sites described above (Fig- G22350 of the coding strand and T22365, G22364, A22363 of the
noncoding strand was observed (Figure 4B). Followingures 4B and 4C). These data indicate that the simple
binding of factors to their regulatory sites is not sufficient PDTC and TNF treatment, IVGF showed that the non-
coding strand within the kB sites of the distal elementfor activation of MCP-1/JE gene expression and suggest
that one or more of the factors that interact with the remained sensitive to DMS, whereas the coding strand
became partially resistant to DMS, suggesting some butMCP-1/JE regulatory regions require modification by
protein kinases. not complete factor occupancy. In contrast, IVGF of
cells treated with PDTC alone (Figure 4C) showed full
protection at the proximal regulatory region (G250 of AP-1PDTC Inhibits the Occupancy of the Noncoding
Strand of the Distal kB Sites binding site, GC box, G bases upstream of kB-3 site,
and site B). Further treatment with TNF did not result inThe role of NF-kB in TNF-mediated induction was exam-
ined by treatment of cells with PDTC. PDTC is an antioxi- alteration of the IVGF pattern. These data suggest that
the proximal sites were utilized during PDTC inductiondant that blocks the activation of NF-kB through the
inhibition of IkB protein degradation (Thompson et al., of MCP-1/JE, and that further induction by TNF is aided
by the distal elements.1995; Schreck et al., 1992; Henkel et al., 1993). Interest-
ingly, in comparison to control cells, incubation of cells Previous studies have shown that the binding of NF-
kB (p50/p65) to kB sites is asymmetric in that the p50with PDTC alone resulted in a 5-fold increase in the level
of MCP-1/JE mRNA. The combined treatment of cells subunit preferentially interacts with the 59 half site and
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Figure 3. CHX Induces Basal Expression of MCP-1/JE, Induces Occupancy of the Proximal Regulatory Region, and Affects the Assembly of
Factors at the Distal Regulatory Region
A Northern blot (A) of RNA prepared from cells treated with cycloheximide and TNF is shown. CHX was added to the cells 2 hr prior to a 2
hr TNF treatment. IVGF assays of the distal (B) and proximal (C) regulatory regions are shown. In vitro methylated genomic DNA (V), DNA
from untreated cells (lane 1), and DNA from cells treated with CHX, TNF, or both, for 30 min are as indicated. Arrows and circles are as
described in Figure 2.
(Figure 3 continued on top of next page)
p65 subunit preferentially interacts with the 39 half site taining either the distal kB sites, the combined AP-1/
(Thanos and Maniatis, 1995a; Urban et al., 1991). If this GC box, the kB-3 site, or site B. EMSA analysis using a
is the case for the homologous kB-1 and kB-2 sites probe encoding both distal kB sites and nuclearextracts
here, then p65 binding (noncoding strand) was inhibited prepared from untreated and TNF-treated BALB/3T3
by PDTC, whereas p50 binding (coding strand) was not. cells revealed three TNF-inducible protein±DNA com-
Alternatively, the absence of high affinity NF-kB proteins plexes, complexes a, b, and c (Figure 5A, lanes 6 and
due to PDTC may either allow lower affinity family mem-
7).The TNF-inducibleprotein±DNA complexes werealso
bers that are not inhibited by PDTC or other non-NF-
detected in the nuclear extracts from cells that were
kB factors to bind to the distal kB sites.
treated with CHX or H7 prior to TNF treatment (Figure
5B, lanes 5 and 6) but were not detected in nuclearTNF-Induced Formation of Protein±DNA Complexes
extracts from cells treated with PDTC and TNF (Figurein the Distal Regulatory Region Involves
5B). All three complexes were specific for the distal kBBoth NF-kB p50 and p65
probe, as specific but not nonspecific DNA competitorsTo investigate further the roles of individual TNF-re-
were able to compete with the probe for DNA bindingsponse elements in the expression of MCP-1/JE, EMSAs
were performed using oligonucleotide probes con- activity. Antisera directed towards members of the c-Rel
TNF Induction of MCP-1/JE
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family of transcription factors (p50, p65, p52, c-Rel, and The Transcription Factors that Occupy the
Combined AP-1/GC Box Site, kB-3 Site,Rel-B) were used in EMSA supershift assays to deter-
mine whether the complexes were composed of known and Site B Are Present in the Nucleus
Prior to TNF Treatmentmembers of the c-Rel family. Complexes a and c were
specifically supershifted by antisera to either p50 or Using the combined AP-1/GC box site as a probe, two
specific protein±DNA complexes, complexes a and b,p65, producing complexes d and e, respectively. This
suggests that the kB sites within this region can bind were detected using nuclear extracts prepared from ei-
ther control, untreated cells, or TNF-treated cells (Figurep50/p50, p65/p65, or p50/p65 dimers (Figure 5C). Be-
cause the probe encodes two kB sites, it is possible 6A, lanes 1 and 6, respectively). The same complexes
were detected using nuclear extracts from cells thatthat complex a represents binding to one of the two kB
sites and complex c represents binding to both sites. were treated with CHX, H7, or PDTC (Figure 6B). There-
fore, the transcription factors that bind to the combinedComplex b is supershifted by p65 antibody only, sug-
gesting that it contains p65/p65 homodimers (Figure AP-1/GC box site were present in the nucleus prior to
TNF treatment. By using antisera specific for c-Fos,5C). Thus, the combined in vitro and in vivodata suggest
strongly that NF-kB is involved in the TNF-mediated c-Jun, SP-1, and ATF-4, complex b was shown to con-
tain SP-1 protein (Figure 6C, lane 4). However, neitherregulation of MCP-1/JE, and that binding to the distal
kB sites occurs following the translocation of that NFkB supershift nor the loss of the complex a or b was ob-
served when antisera specific for c-Fos or c-Jun wasto the nucleus upon TNF treatment.
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Figure 4. H7 and PDTC Affect the TNF Induction of MCP-1/JE but Have Different Consequences on the Occupancy of the Regulatory Regions
Northern blot analysis (A) of TNF-induced MCP-1/JE mRNA level in cells incubated in the presence and absence of 0.1 mM H7 or 0.1 mM
PDTC for 60 and 90 min, respectively, prior to the addition of TNF. TNF treatment was for 2 hr. IVGF assays of the distal (B) and proximal (C)
regulatory regions are shown. In vitro methylated genomic DNA (V), DNA from untreated cells (lane 1), and DNA from cells treated with H7,
PDTC, or TNF for 30 min are as indicated. Arrows and circles are as described in Figure 2.
(Figure 4 continued on top of next page)
added. Also, no competition was observed when an The same protein±DNA complex was also observed us-
ing nuclear extracts from cells that were treated withauthentic AP-1 oligonucleotide was added as a specific
competitor in these EMSAs (Figures 6A and 6B). These CHX, H7, or PDTC (Figures 7A and 7B). These experi-
ments indicate that the transcription factors that binddata suggest that the combined AP-1/GC box site func-
tions as a SP-1 site and not an AP-1 site. to kB-3 and site B are already present in the nucleus
prior to TNF treatment. To determine whether kB-3 bindsRegardless of whether the nuclear extracts were pre-
pared from control, untreated cells, or TNF-treated cells, NF-kB, DNA encoding kB-1 and kB-2 was used as com-
petitor DNA in the EMSA. No competition was observeda protein±DNA complex was detected in EMSAs using
probes containing kB-3 or site B (Figures 7A and 7B). (data not shown). Additionally, antisera specific for
TNF Induction of MCP-1/JE
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members of the c-Rel family of transcription factors The Proximal Regulatory Region Controls
the Basal Transcriptional Activity(p50, p65, p52, c-Rel, and Rel-B), the c-Fos, c-Jun, SP-1,
CREB, and others were used in EMSA supershift assays of Murine MCP-1/JE Gene
Three potential regulatory sites were identified in thebut had no effect on the EMSA pattern (data not shown).
Thus, the kB-3-binding factor remains to be identified. proximal regulatory region of murine MCP-1/JE gene:
the combined AP-1/GC box site, site B, and kB-3. Fac-The combined EMSA analysis demonstrates that the
tors binding tosite B and kB-3 are currently uncharacter-proximal regulatory region DNA-binding proteins are
ized and their roles in the expression of MCP-1/JEpresent in the nucleus prior to TNF treatment and are
are under investigation. The MCP-1/JE AP-1 site (TGAable to bind in vitro, but not in vivo. This also implies
CTCC), which is conserved in the human (Ueda et al.,that protein modification is not required for factor bind-
1994) and rat (Timmers et al., 1990) MCP-1/JE genes,ing and site occupancy.
differs from the consensus AP-1 sequence (TGACTCA)
by 1 bp (Timmers et al., 1990). A role for the AP-1 siteDiscussion
in the TNF and transforming growth factor b regulation
of murine MCP-1/JE expression has been suggested byThe above analyses demonstrate the involvement of
many sites and factors controlling the regulation of the studies that showed decreases in MCP-1/JE expression
when either antisense DNAs targeting c-Jun or c-FosMCP-1/JE gene by TNF. IVGF, which provides a snap-
shot of the sites utilized in vivo, revealed that TNF in- (Hanazawa et al., 1993; Takeshita et al., 1995) or inhibi-
tors of c-Jun or c-Fos activities were used (Hanazawaduces the binding of both induced factors, such as NF-
kB, as well as factors already present in the nucleus. et al., 1994). Other studies have suggested that the adja-
cent GC box of thehuman MCP-1/JE gene is responsibleOnly site A was occupied prior to TNF treatment. The
induced occupancy of both proximal and distal sites for the maintenance of basal transcriptional activity of
MCP-1/JE (Ueda et al., 1994). The combined IVGF andsuggests that at least one or possibly two multiprotein
complexes or enhanceosomes are assembled in re- EMSA data for the GC box are consistent with a role for
SP-1 in TNF-mediated expression. The lack of occu-sponse to TNF to regulate the MCP-1/JE gene. The
composition and roles of each of the regulatory regions pancy at this site in untreated cells is consistent with
the low level of expression observed by Northern blotare discussed below.
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Figure 5. TNF-Activated NF-kB p50 and p65
Bind to the Distal kB Sites in EMSAs
EMSAs were carried out on nuclear extracts
prepared from control cells (2TNF) and cells
treated with TNF for 30 min (1TNF). The
probe, which contains both kB-1 and kB-2
sites and was generated by PCR (22331 to
22390), is schematically shown at the bottom
of the figure.
(A) Three protein±DNA complexes, a, b, and c,
are indicated. DNA competitors (35 ng each),
unlabeled kB DNA, kB-3 DNA, and the AP-1/
GC box DNA were added 5 min prior to the
addition of probe. Poly (dIdC):poly (dIdC)
(0.625 mg) was included in all reactions ex-
cept lanes 2 and 7, which contained 1.3 mg.
(B) EMSAs were performed on nuclear ex-
tracts prepared from cells that were pre-
treated with CHX (25 mg/ml), H7 (0.1 mM),
PDTC (0.1 mM), or TNF as above.
(C) EMSAs of nuclear extracts prepared from
TNF-treated (30min) and untreated cells were
carried out in the presence of the indicated
kB-reactive antisera. Complexes a, b, and c
are the same as for (A), whereas d and e indi-
cate complexes that are supershifted by p50-
and p65-specific antisera, respectively.
analysis, as factor occupancy in a small percentage of using the combined AP-1/GC box as a probe showed
no clear binding of AP-1. Interestingly, a similar IVGFthe cells in culture would not be detected by IVGF. A
recent study has shown interactions between NF-kB analysis performed on a C3H-derived fibroblast cell line,
C3HA, showed full protection of both the AP-1 and SP-1and SP-1 elements (Pazin et al., 1996). If such interac-
tions occurred in the MCP-1/JE gene, this would serve sites (data not shown). This result may suggest cell line
differences in the role of AP-1 in regulating MCP-1/JE.to link the distal and proximal regulatory regions.
The role of the AP-1 site is not as clear. Although Although EMSAs showed that factors that bind to the
proximal sites were present in the nucleus of untreatedadditional base pairs within the AP-1 site were occasion-
ally protected following TNF treatment, this observation cells, the level of MCP-1/JE mRNA in untreated cells
was low. However, after cells were treated with CHX orwas not consistent. Furthermore, although control EM-
SAs showed that AP-1 was present in the cells (data not PDTC, a substantial increase in MCP-1/JE mRNA level
was detected without formation of new or enhancedshown), EMSA analysis and antibody supershift assays
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proximal regulatory region that was similar to the occu-
pancy observed upon TNF treatment. Thus, treatment
of cells with CHX, PDTC, or TNF either initiates post-
translational modification processes that activate the
transcription factors, alter the chromatin structure of
the MCP-1/JE gene from an inactive ground state to a
derepressed state (Paranjape et al., 1994), or both, to
initiate regulatory site occupancy and transcription.
TNF Induction of the Murine MCP-1/JE Gene
Involves the Assembly of a Multicomponent
Complex in the Distal Regulatory Region
Compared with the identified kB sequences (Miyamoto
and Verma, 1995), the kB-2 site is identical to the kB
sites found in the IkBa gene, and kB-1 has a one base
mismatch with the consensus sequence (GGGRNNY-
YCC). Since TNF induces the binding of transcription
factors to bothsites with kinetics similar to the activation
profile of NF-kB proteins by TNF (Thompson et al., 1995),
it is likely that both sites are functional NF-kB binding
sites in vivo. Using the kB sites as a probe in EMSAs,
the TNF-inducible protein±DNA complexes were shown
to contain p50 and p65. However, in the experiments
reported here it was not possible to determine which
NF-kB complex (e.g., p65/p65 or p65/p50) was bound
at each of the sites.
IVGF of cells treated with TNF showed that TNF in-
duces not only the protection of the kB-1 and kB-2 sites
but also the appearance of DMS-hypersensitive base
pairs between the two kB sites. DMS-hypersensitive
sites indicate changes in the conformation of the DNA
that could be due to DNA bending. The presence of
both protected and DMS-hypersensitive bases over this
region suggests the formation of a multiprotein complex
similar to that described for the interferon b (IFNb)
(Thanos et al., 1993) and endothelial cell adhesion mole-
cule (Collins et al., 1995) genes. The distal regulatory
complex involves the NF-kB (or kB-like) proteins that
bind to both kB sites and an additional unknown tran-
scription factor(s). One possible additional factor may
be theHMG-I/Y. HMG-I/Y is a minor groove DNA-binding
protein that bends DNA upon binding (Grosschedl et al.,
Figure 6. The AP-1/GC Box Site Binds the Transcription Factor 1994). HMG-I/Y has been found to stabilize the binding
SP-1, Which Is Present in the Nucleus Prior to TNF Treatment
and assembly of multicomponent protein±DNA com-
Oligonucleotides encoding the AP-1/GC box (base pairs 266 to
plexes that include NF-kB and ATF-2 (Thanos et al.,233) were used in EMSAs prepared from cells as described in Fig-
1993; John et al., 1995; Lewis et al., 1994). The kB-2 siteure 5.
(A and B) Two specific protein±DNA complexes, a and b, identified contains an A±T-rich region in its center that is similar
in the nuclear extracts from both TNF-treated and untreated cells to the kB/HMG-I/Y motif found in the IFNb enhancer
are indicated. The protein±DNA complex designated as ns is non-
(Thanos and Maniatis, 1992). It is likely that NF-kB p50specific. DNA competitors included DNA containing a consensus
and p65 are not involved directly in the formation of theAP-1 site (TGACTCA), site B DNA, and unlabeled probe DNA as
indicated. hypersensitive site as treatment with PDTC and TNF,
(C) EMSAs of nuclear extracts prepared from TNF-treated (30 min) which prevented NF-kB nuclear translocation in this cell
and untreated cells were carried out in the presence of the indicated line, did not prevent formation of the hypersensitive site.
antisera show that complex B reacts with SP-1 antisera.
Moreover, the partial protection of kB-2 following PDTC
and TNF treatment may suggest that other c-rel family
members that are not affected by PDTC are activatedprotein±DNA complexes as determined in vitro by
EMSA. This apparent inconsistency was resolved by in response to TNF and function in controlling MCP-
1/JE. Alternatively, the absence of the NF-kB factorsIVGF analysis. While control cells showed no protein
occupancy in the proximal regulatory region, treatment following PDTC treatment may allow the binding of sec-
ondary factors.with CHX or PDTC resulted in full occupancy of the
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Figure 7. The kB-3 Site and Site B Bind to Factors that Are Present in the Nucleus Prior to TNF Treatment
EMSAs were carried out as in Figure 5. The probe containing (A) kB-3 site (2135 to 2169) or (B) site B (259 to 288) was generated from
annealing complimentary oligos as described in Experimental Procedures.
Protein Synthesis and Posttranslational Processes H7, a serine/threonine protein kinase inhibitor, has
been shown to inhibit the TNF induction of MCP-1/JEAre Required for Full TNF-Mediated
Induction of MCP-1/JE and other genes (Hanazawa et al., 1993; Mattila et al.,
1992; Cao et al., 1992; Montgomery et al., 1991). InTreatment of cellswith CHX and the protein kinase inhib-
itor H7 provided important clues to the mechanisms BALB/3T3 cells, H7 inhibits the TNF induction of MCP-
1/JE in a dose-dependent manner with no inhibition atof MCP-1/JE regulation. Although CHX treatment alone
had been reported to activate NF-kB proteins (Henkel 5 mM and 100% inhibition at 60 mM (data not shown).
H7 (100 mM) was used in these experiments to ensureet al., 1993), this was not observed in either the in vitro
EMSA or in vivo IVGF assays. CHX did not prevent the that the footprinting data fully reflect the effects of H7.
However, even at 100 mM H7, the TNF-induced bindingTNF-mediated activation of p50 or p65 as determined
by in vitro EMSA; however, IVGFanalyses of cells treated of transcription factors to both the distal and the proxi-
mal regulatory regions was not inhibited. Therefore,with both CHX and TNF showed that kB-1 was not pro-
tected, whereas kB-2 showed only slight protection TNF-initiated signal transduction pathways that lead to
the binding of transcription factors to their regulatorywhen cells were pretreated with CHX for 2 hr prior to
TNF treatment. Thestrong hypersensitivesite is reduced sites in the MCP-1/JE gene do not require a phosphory-
lation step. Despite the fact that occupancy of bothconsiderably under these conditions as well. Thus, it
appears as though CHX treatment results in the loss of regulatory regions was complete, transcription was not
activated. These data suggest that at least one of thea factor required for complete occupancy of the distal
kB sites. The fact that TNF still superinduces the expres- factors required for activation of the MCP-1/JE gene by
TNF requires phosphorylation.sion of MCP-1/JE in the presence of CHX suggests that
this induction may either occur at the proximal regula- These studies begin to define a bipartite regulatory
system for MCP-1/JE with the distal regulatory regiontory region, which is fully occupied, or that the partially
protected distal region is sufficient to allow the 2-fold required for TNF-induced expression and the proximal
regulatory region required for all aspects of expression,increase in expression. Another contributing factor is
the possibility that CHX treatment extends the half-life including the response to cellular stress (Figure 8). The
above analysis also suggests several levels in whichof the MCP-1/JE mRNA, which under normal circum-
stances is extremely short (unpublished data), thereby cell-type specific responses to TNF may be controlled.
These levels include the accessibility of the regulatoryincreasing steady-state mRNA levels without increasing
the transcription rate. regions to factors required for expression, the release
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DNA Constructions and Transient Transfection Assays
The DNA fragments for the six MCP-1/JE promoter fusion reporter
constructions shown in Figure 1 were generated from BALB/3T3
genomic DNA by PCR amplification using PfuI polymerase and the
following primer sets: pJECAT2.6, 59-ACGTTCCATTGTCCATCTG
GGT-39 and 59-GGTGGTGGAGGAAGAGAGAG-39; pJECAT2.5, 59-CA
AGCCAGAGCTCAGACTAGGCCT-39 and 59-GGTGGTGGAGGAAGA
GAGAG-39; pJECAT2.4, 59-CCGAAGGGTCTGGGAACTT-39 and 59-
GGTGGTGGAGGAAGAGAGAG-39; pJECAT2.3, 59-ACGCTCTTATC
CTACTCTGCCTC-39 and 59-GGTGGTGGAGGAAGAGAGAG-39;
pJECAT0.3, 59-CAGTGAAAGCAGAGCCACTCCATTCAC-39 and 59-
GGTGGTGGAGGAAGAGAGAG-39. Amplified DNA fragments were
subcloned into pCATBasic vector DNA that was linearized with XbaI
and filled in with the Klenow fragment of DNA polymerase. Transient
transfections were carried out by electroporation of 20 mg of DNA
as previously described (Riley and Boss, 1993) using approximately
5 3 106 cells/assay. TNF (500 U) was added at 36 hr posttransfection,
and extracts were prepared from cells 12 hr later as described
previously (Riley and Boss, 1993). CAT protein expression was as-
sayed using the CAT±ELISA kit supplied by Boerhinger Mannheim,
Incorporated. All constructions were assayed at least three times.
The data from these assays were averaged and analyzed for statisti-
cal significance using the Student's t test.
IVGF
In vivo methylation of cellular DNA and DNA preparation were per-
formed as described in Mueller et al. (1994). The ligation-mediated
PCR for footprinting was carried out according to the procedure
of Mueller et al. (1994) with minor modification. Primer fill-in and
amplification reactions were carried out using Vent Polymerase
(New England Biolabs, Incorporated) with 0.4 mM each of dATP,
dCTP, dGTP, and dTTP in the buffer recommended by the vendor.
Ligation of the common linker (Mueller et al., 1994) was carried out
overnight at 168C using 3 U of T4 DNA ligase (GIBCO BRL) in the
buffer provided by the manufacturer. The distal regulatory region
and the proximal regulatory region were each analyzed by one set
of upper-strand and one set of lower-strand primers. The sequences
Figure 8. Model of TNF-Induced Regulation of the Murine MCP- of the coding-strand primers for the distal regulatory region are as
1/JE Gene follows: JENFkB3-1, 59-TCACCATTGCAAAGTGAATTGGC-39;
In the uninduced state, factors at site A are bound to the DNA and JENFkB3-2, 59-AGTTAGC AC AGGAGGC AGCGC AA-39 ; and
the other factors are either in the nucleus or cytoplasm but are not JENFkB3-3, 59-CACAGGAGGCAGCGCAAATGTGAATCA-39. The
bound to DNA. Expression during stress, such as when protein sequences of the noncoding-strand primers for the distal regulatory
synthesis is inhibited, involves the assembly of nuclear factors and region are as follows: JENFkB5-1, 59-CAAGCCAGAGCTCAGACTAG
activation through the proximal control region, potentially with fac- GCCT-39; JENFkB5-2, 59-TCAGATTCTCCGGCCCATGAGAGA-39;
tors at site A. Induction by TNF involves the translocation to the and JENFkB5-3, 59-CTCCGGCCCATGAGAGAACTGCTTGG-39. The
nucleus of NF-kB, the assembly of all the factors on the DNA, and sequences of the coding-strand primers for the proximal regulatory
the activation of one or more of the factors by phosphorylation as region are as follows: JE3-1, 59-AACTGTGAACAGCAGGCCCAGAA-
indicated by the shading. 39; JE3-2, 59-AGAAGCATGACAGGGACCTGCATGGT-39; and JE3-3,
59-GACAGGGACCTGCATGGTGGTGGAGGA-39. The sequences of
the noncoding-strand primers for the proximal regulatory region
are as follows: JE5-7, 59-CCCCCTACTCCCTGCGCA-39; JE5-8, 59-
and translocation to the nucleus of transcription factors TCATTTGCTCCCAGGAGTGGCTAG-39; and JE5-9, 59-GCTCCCAG
GAGTGGCTAGAAAAATACCA-39.held in the cytoplasm, the assembly of both induced
and ªresidentº nuclear transcription factors into a multi-
Nuclear Extracts and EMSAsprotein complex, and finally the activation of some of
Nuclear extracts were prepared from z108 cells according to the
the factors by a kinase. Cells unable to comply with any procedures of Shapiro et al. (1988) and as we have previously de-
of these steps would therefore be unable to activate scribed (Hasegawa et al., 1991, 1993). DNA binding assays were
carried out on ice and the probes were incubated with z2 mg nuclearthat gene in response to TNF.
extract in the appropriate reaction buffer for 30 min prior to loading
on a 5% polyacrylamide gel. Electrophoresis was carried out at 48C
with recirculating buffer (Hasegawa et al., 1991). The reaction bufferExperimental Procedures
contained 15 mM HEPES (pH 7.9), 10% glycerol, 50 mM KCl, 0.12
mM EDTA, 5 mg BSA, 1 mM dithiothreitol (DTT), and 5 mM MgCl2.Cells and Cell Culture
BALB/3T3 clone A31 (American Type Culture Collection, CCL-163) To assay for NF-kB binding activity, NP-40 (0.05%), and GTP (3 mM)
were added to the above reaction buffer. The final concentration ofand NIH 3T3 fibroblasts were grown in Dulbecco's modified Eagle's
media supplemented with penicillin (50 U/ml), streptomycin (50 DTT in reactions that assayed for AP-1/GC box binding activities
was 12 mM. Antibody supershift assays were carried out by addingmg/ml), and 10% calf serum (Intergen, Incorporated). Human recom-
binant TNF (Creasey et al., 1987; Wang et al., 1985) was provided 1 ml of antibody (Santa Cruz Biotechnology, Incorporated) to the
reaction mixture 5 min prior to the addition of the labeled probe.by Chiron Corporation. Cells were grown to 90%±95% confluence
and then treated with 500 U/ml TNF for the indicated time period. The sequences of the coding strand of DNAs used in EMSAs were
as follows: kB, 59-CCCGAAGGGTCTGGGAACTTCCAATACTGCCTCHX, PDTC, and H7 were purchased from Sigma, Incorporated, and
added 2 hr, 1.5 hr, and 1 hr, respectively, prior to TNF. CAGAATGGGAATTTCCACGCTCTTATCC; AP-1/GC box, 59-GCACC
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CTGCCTGACTCCACCCCCCTGGCTTACAA; kB-3, 59-TCTCTTCCA suppression of c-fos gene inhibits expression of tumor necrosis
factor-a±induced monocyte chemoattractant JE/MCP-1 in clonalCTTCCTGGAAACACCCGAGGCTCTG; site B, 59-TGATGCTACTC
CTTGGCACCAAGCACCCTG; and AP-1, 59-CTAGTGATGAGTCAGC osteoblastic MC3T3±E1 cells. J. Biol. Chem. 269, 21379±21384.
CGGAT. Hasegawa, S.L., Sloan, J.H., Reith, W., Mach, B., and Boss, J.M.
(1991). Regulatory factor-X binding to mutant HLA-DRA promoter
RNA Analysis sequences. Nucl. Acids Res. 19, 1243±1249.
RNA was prepared from one 10 cm plate of cells grown to near Hasegawa, S.L., Riley, J.L., Sloan, J.H., andBoss, J.M. (1993). Prote-
confluence using the NP-40 lysis method as described (Sambrook ase treatment of nuclear extracts distinguishes between class II
et al., 1989; Gordon et al., 1992). RNA blot analysis was carried out major histocompatibility complex X1 box DNA-binding proteins in
under standard conditions using formaldehyde gels (Gordon et al., wild type and class II deficient B cells. J. Immunol. 150, 1781±1793.
1992). Approximately 5 mg of RNA was loaded in each lane. cDNA
Henkel, T., Machleldt, T., Alkalay, I., Kronke, M., Ben-Nerlah, Y., andprobes were labelled by a random primed DNA labeling kit (Boeh-
Baeuerle, P.A. (1993). Rapid proteolysis of IkB-a is necessary forringer Mannheim, Incorporated), and hybridization was carried out
activation of transcription factor NF-kB. Nature 365, 182±185.at 688C in QuikHyb (Stratagene, Incorporated) for 1 hr. Filters were
Hotamisligil, G.S., and Spiegelman, B.M. (1994). Tumor necrosiswashed three times for 20 min each at 688C in 23 SSC, 13 SSC,
factor a: a key component of the obesity±diabetes link. Diabetesand 0.53 SSC, together with 0.1% SDS (13 SSC contained 0.15 M
43, 1271±1278.sodium chloride, 0.015 M sodium citrate [pH 7.0]). Northern blots
were exposed to phosphorimaging screens and the data were ana- Ito, C.Y., Kazantsev, A.G., and Baldwin, A.S., Jr. (1994). Three NF-
lyzed on a Molecular Dynamics PhosphorImager. GAPDH was used kB sites in the IkB-a promoter are required for induction of gene
as an internal standard to normalize total mRNA in each lane. expression by TNFa. Nucl. Acids Res. 22, 3787±3792.
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